abstract |
The present invention provides a pharmaceutical agent containing a combination of a HER2 inhibitor and a hormone therapy or anticancer agent. The present invention provides a pharmaceutical agent containing a combination of (1) an HER2 inhibitor having a pyrrolopyrimidine backbone or a pyrazolopyrimidine backbone, and (2) a hormone therapeutic or anticancer agent. |